8-K//Current report
Spyre Therapeutics, Inc. 8-K
Accession 0001636282-25-000050
$SYRECIK 0001636282operating
Filed
May 7, 8:00 PM ET
Accepted
May 8, 4:05 PM ET
Size
348.5 KB
Accession
0001636282-25-000050
Documents
- 8-Ksyre-20250508.htmPrimary
8-K
- EX-99.1spyre-20250331xexx991.htm
EX-99.1
- EX-101.SCHsyre-20250508.xsd
XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
- EX-101.LABsyre-20250508_lab.xml
XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
- EX-101.PREsyre-20250508_pre.xml
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
- GRAPHICspyre-logoxhorizontalxfulla.jpg
- XMLR1.htm
IDEA: XBRL DOCUMENT
- EXCELFinancial_Report.xlsx
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001636282-25-000050-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLsyre-20250508_htm.xml
IDEA: XBRL DOCUMENT
Issuer
Spyre Therapeutics, Inc.
CIK 0001636282
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001636282
Filing Metadata
- Form type
- 8-K
- Filed
- May 7, 8:00 PM ET
- Accepted
- May 8, 4:05 PM ET
- Size
- 348.5 KB